3,4-Dimethoxycinnamic acid t-amides, prepared with various aliphatic and cycloaliphatic amines, were found to be useful in evaluating analgesic and antiinflammatory effects. 1 Amongst these, the title compound (the only one which could be crystallized suitably) had shown an analgesic effect comparable to reference drugs, but lacked antiinflammatory activity. As far as the amide function is concerned, prolongation of the chain length of the alkyl groups and cyclization decreased an in vivo antiinflammatory effect, in contrast to analgesic activity. On the other hand, the stereochemistry of the biologically active compounds plays an important role in drug-receptor interactions. In this study, we aimed to define the geometry of (C15H19NO3) (I) (Fig. 1 ) by X-ray crystallography and conformational analysis to understand the analgesic activity of the cycloaliphatic amine part of (I).
The compound was obtained by the reaction of 3,4-dimethoxycinnamic acid with pyrrolidine by the DCC/HOBt method, and was crystallized from diethylether-ethanol. 1 Its melting point is 142.5˚C.
X-ray data were collected by graphite-monochromated Mo Kα radiation (λ = 0.71069 Å). 2 The crystal structure was solved by direct methods. 3 All the non-hydrogen atoms were refined anisotropically (hydrogen atoms were included, but not refined). 4 The crystal and experimental data are listed in Table  1 . The final fractional atomic coordinates and equivalent isotropic thermal parameters for non-hydrogen atoms are given in Table 2 Table 1 Crystal and structure refinement data for the title compound Table 3 Bond lengths (Å) and angles (˚) with e.s.d.'s in parentheses Fig. 2 Molecular structure of the title compound along with the atom labeling. Thermal ellipsoids are drawn at the 50% probability level.
